Enhancement of CYP3A4 activity in hep G2 cells by lentiviral transfection of hepatocyte nuclear factor-1 alpha

Tsai Shin Chiang, Kai Chiang Yang, Ling Ling Chiou, Guan Tarn Huang, Hsuan Shu Lee

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Human hepatoma cell lines are commonly used as alternatives to primary hepatocytes for the study of drug metabolism in vitro. However, the phase I cytochrome P450 (CYP) enzyme activities in these cell lines occur at a much lower level than their corresponding activities in primary hepatocytes, and thus these cell lines may not accurately predict drug metabolism. In the present study, we selected hepatocyte nuclear factor-1 alpha (HNF1a) from six transcriptional regulators for lentiviral transfection into Hep G2 cells to optimally increase their expression of the CYP3A4 enzyme, which is the major CYP enzyme in the human body. We subsequently found that HNF1a-transfected Hep G2 enhanced the CYP3A4 expression in a timeand dose-dependent manner and the activity was noted to increase with time and peaked 7 days. With a multiplicity of infection (MOI) of 100, CYP3A4 expression increased 19-fold and enzyme activity more than doubled at day 7. With higher MOI (1,000 to 3,000), the activity increased 8- to 10-fold; however, it was noted the higher MOI, the higher cell death rate and lower cell survival. Furthermore, the CYP3A4 activity in the HNF1a-transfected cells could be induced by CYP3A4- specific inducer, rifampicin, and metabolized nifedipine in a dose-dependent manner. With an MOI of 3,000, nifedipinemetabolizing activity was 6-fold of control and as high as 66% of primary hepatocytes. In conclusion, forceful delivery of selected transcriptional regulators into human hepatoma cells might be a valuable method to enhance the CYP activity for a more accurate determination of drug metabolism in vitro.

Original languageEnglish
Article numbere94885
JournalPLoS One
Volume9
Issue number4
DOIs
Publication statusPublished - Apr 14 2014

Fingerprint

Hepatocyte Nuclear Factor 1-alpha
Cytochrome P-450 CYP3A
Hep G2 Cells
transfection
Cytochrome P-450 Enzyme System
hepatocytes
Transfection
Cells
Metabolism
Hepatocytes
cytochrome P-450
pharmacokinetics
Enzyme activity
Infection
Cell Line
cell lines
cells
hepatoma
Hepatocellular Carcinoma
infection

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Enhancement of CYP3A4 activity in hep G2 cells by lentiviral transfection of hepatocyte nuclear factor-1 alpha. / Chiang, Tsai Shin; Yang, Kai Chiang; Chiou, Ling Ling; Huang, Guan Tarn; Lee, Hsuan Shu.

In: PLoS One, Vol. 9, No. 4, e94885, 14.04.2014.

Research output: Contribution to journalArticle

Chiang, Tsai Shin ; Yang, Kai Chiang ; Chiou, Ling Ling ; Huang, Guan Tarn ; Lee, Hsuan Shu. / Enhancement of CYP3A4 activity in hep G2 cells by lentiviral transfection of hepatocyte nuclear factor-1 alpha. In: PLoS One. 2014 ; Vol. 9, No. 4.
@article{78d1f84c8d1841a6891a7533bba7b788,
title = "Enhancement of CYP3A4 activity in hep G2 cells by lentiviral transfection of hepatocyte nuclear factor-1 alpha",
abstract = "Human hepatoma cell lines are commonly used as alternatives to primary hepatocytes for the study of drug metabolism in vitro. However, the phase I cytochrome P450 (CYP) enzyme activities in these cell lines occur at a much lower level than their corresponding activities in primary hepatocytes, and thus these cell lines may not accurately predict drug metabolism. In the present study, we selected hepatocyte nuclear factor-1 alpha (HNF1a) from six transcriptional regulators for lentiviral transfection into Hep G2 cells to optimally increase their expression of the CYP3A4 enzyme, which is the major CYP enzyme in the human body. We subsequently found that HNF1a-transfected Hep G2 enhanced the CYP3A4 expression in a timeand dose-dependent manner and the activity was noted to increase with time and peaked 7 days. With a multiplicity of infection (MOI) of 100, CYP3A4 expression increased 19-fold and enzyme activity more than doubled at day 7. With higher MOI (1,000 to 3,000), the activity increased 8- to 10-fold; however, it was noted the higher MOI, the higher cell death rate and lower cell survival. Furthermore, the CYP3A4 activity in the HNF1a-transfected cells could be induced by CYP3A4- specific inducer, rifampicin, and metabolized nifedipine in a dose-dependent manner. With an MOI of 3,000, nifedipinemetabolizing activity was 6-fold of control and as high as 66{\%} of primary hepatocytes. In conclusion, forceful delivery of selected transcriptional regulators into human hepatoma cells might be a valuable method to enhance the CYP activity for a more accurate determination of drug metabolism in vitro.",
author = "Chiang, {Tsai Shin} and Yang, {Kai Chiang} and Chiou, {Ling Ling} and Huang, {Guan Tarn} and Lee, {Hsuan Shu}",
year = "2014",
month = "4",
day = "14",
doi = "10.1371/journal.pone.0094885",
language = "English",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Enhancement of CYP3A4 activity in hep G2 cells by lentiviral transfection of hepatocyte nuclear factor-1 alpha

AU - Chiang, Tsai Shin

AU - Yang, Kai Chiang

AU - Chiou, Ling Ling

AU - Huang, Guan Tarn

AU - Lee, Hsuan Shu

PY - 2014/4/14

Y1 - 2014/4/14

N2 - Human hepatoma cell lines are commonly used as alternatives to primary hepatocytes for the study of drug metabolism in vitro. However, the phase I cytochrome P450 (CYP) enzyme activities in these cell lines occur at a much lower level than their corresponding activities in primary hepatocytes, and thus these cell lines may not accurately predict drug metabolism. In the present study, we selected hepatocyte nuclear factor-1 alpha (HNF1a) from six transcriptional regulators for lentiviral transfection into Hep G2 cells to optimally increase their expression of the CYP3A4 enzyme, which is the major CYP enzyme in the human body. We subsequently found that HNF1a-transfected Hep G2 enhanced the CYP3A4 expression in a timeand dose-dependent manner and the activity was noted to increase with time and peaked 7 days. With a multiplicity of infection (MOI) of 100, CYP3A4 expression increased 19-fold and enzyme activity more than doubled at day 7. With higher MOI (1,000 to 3,000), the activity increased 8- to 10-fold; however, it was noted the higher MOI, the higher cell death rate and lower cell survival. Furthermore, the CYP3A4 activity in the HNF1a-transfected cells could be induced by CYP3A4- specific inducer, rifampicin, and metabolized nifedipine in a dose-dependent manner. With an MOI of 3,000, nifedipinemetabolizing activity was 6-fold of control and as high as 66% of primary hepatocytes. In conclusion, forceful delivery of selected transcriptional regulators into human hepatoma cells might be a valuable method to enhance the CYP activity for a more accurate determination of drug metabolism in vitro.

AB - Human hepatoma cell lines are commonly used as alternatives to primary hepatocytes for the study of drug metabolism in vitro. However, the phase I cytochrome P450 (CYP) enzyme activities in these cell lines occur at a much lower level than their corresponding activities in primary hepatocytes, and thus these cell lines may not accurately predict drug metabolism. In the present study, we selected hepatocyte nuclear factor-1 alpha (HNF1a) from six transcriptional regulators for lentiviral transfection into Hep G2 cells to optimally increase their expression of the CYP3A4 enzyme, which is the major CYP enzyme in the human body. We subsequently found that HNF1a-transfected Hep G2 enhanced the CYP3A4 expression in a timeand dose-dependent manner and the activity was noted to increase with time and peaked 7 days. With a multiplicity of infection (MOI) of 100, CYP3A4 expression increased 19-fold and enzyme activity more than doubled at day 7. With higher MOI (1,000 to 3,000), the activity increased 8- to 10-fold; however, it was noted the higher MOI, the higher cell death rate and lower cell survival. Furthermore, the CYP3A4 activity in the HNF1a-transfected cells could be induced by CYP3A4- specific inducer, rifampicin, and metabolized nifedipine in a dose-dependent manner. With an MOI of 3,000, nifedipinemetabolizing activity was 6-fold of control and as high as 66% of primary hepatocytes. In conclusion, forceful delivery of selected transcriptional regulators into human hepatoma cells might be a valuable method to enhance the CYP activity for a more accurate determination of drug metabolism in vitro.

UR - http://www.scopus.com/inward/record.url?scp=84899624433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899624433&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0094885

DO - 10.1371/journal.pone.0094885

M3 - Article

C2 - 24733486

AN - SCOPUS:84899624433

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e94885

ER -